> 资讯
Ad hoc announcement pursuant to Art. 53 LR
Baar (Switzerland), 21 January 2025
Based on preliminary unaudited figures, Ascom reports for fiscal year 2024 a revenue of CHF 286.7 million, which is a decline of 1.6% at constant currencies, and an EBITDA margin of around 7.5%.
In a continuing challenging market environment, Ascom generated net revenue of CHF 286.7 million for fiscal year 2024 (2023: CHF 297.3 million), which reflects a decline of 1.6% at constant currencies and of 3.6% at actual currencies compared to the previous year, based on preliminary unaudited figures.
Revenue development showed a mixed picture. The best performance was achieved in the key markets Nordics, DACH, the Netherlands, and Italy, while UK and the OEM business underperformed due to lower market traction than expected and project delays in the last quarter of 2024. The especially disappointing results in USA & Canada and France & Spain have also triggered a management change and both regions have new Managing Directors as of January 2025.
Incoming orders came to CHF 307.4 million (2023: CHF 318.6 million), representing a decline of 1.5% at constant currencies and of 3.5% at actual currencies. The order backlog stood at CHF 301.5 million as of year-end 2024 (31.12.2023: CHF 276.4 million).
Due to the lower revenue and higher investments in Research & Development (R&D) as well as in Marketing & Sales, Ascom achieved for fiscal year 2024 a lower EBITDA margin of around 7.5% (2023: EBITDA margin of 10.1%). Considering the lower EBITDA and higher costs for depreciation and amortization due to investments in R&D and ERP (Enterprise Resource Planning), the 2024 Group profit will be substantially lower than in the previous year and is expected to be in the range of CHF 3 to 4 million, also impacted by a non-cash one-off adjustment of about CHF 2 million.
Ascom continues to have a solid balance sheet with a net cash position of CHF 18.6 million as of year-end 2024 (31.12.2023: CHF 24.7 million) and an equity ratio of around 39%.
Annual Media Conference 2025
The full details of the financial statements and the 2024 Annual Report, including dividend proposal and 2025 guidance, will be published on 12 March 2025.
Contact
Daniel Lack
Senior VP Legal & Communications / IR
+41 41 544 78 10
daniel.lack@ascom.com
Investor@ascom.com
相关推荐
- Ascom preliminary results 2024
- CBL International Limited受邀纳斯达克访谈,探讨可持续燃料愿景
- CBL International Limited invited to Nasdaq interview, discussing vision for sustainable fuels
- 招商蛇口 | 筑造每一个有温度的家
- inDare格外设计携手PLAUD.AI亮相2025 CES,赋能AI硬件场景应用
- 年货进京1号线 有“蛇”有得新年见——热烈庆祝云南麻栗坡县吴侨茶业有限责任公司入选北京地铁1号线年货进京专列
- “从研出发,噬浪而行”——走进山东新航线生物科技有限公司的噬菌航线
- 挂面进京1号线 美味新年共品鉴——热烈庆祝陕西多米健康制药有限公司入选北京地铁1号线年货进京专列
- 首届“股神争霸赛”颁奖典礼暨年终嘉年华在成都圆满落幕,投资盛宴精彩纷呈
- 年货进京1号线 戈壁红驼从草原到首都,共赴乡村振兴新征程——热烈庆祝内蒙古戈壁红驼生物科技有限责任公司入选北京地铁1号线年货进京专列
- 搜索
-
- 01-21Ascom preliminary results 2024
- 01-21CBL International Limited受邀纳斯达克访谈,探讨可持续燃料愿景
- 01-21CBL International Limited invited to Nasdaq interview, discussing vision for sustainable fuels
- 01-21招商蛇口 | 筑造每一个有温度的家
- 01-21inDare格外设计携手PLAUD.AI亮相2025 CES,赋能AI硬件场景应用
- 01-21年货进京1号线 有“蛇”有得新年见——热烈庆祝云南麻栗坡县吴侨茶业有限责任公司入选北京地铁1号线年货进京专列
- 01-21“从研出发,噬浪而行”——走进山东新航线生物科技有限公司的噬菌航线
- 01-21挂面进京1号线 美味新年共品鉴——热烈庆祝陕西多米健康制药有限公司入选北京地铁1号线年货进京专列
- 01-21首届“股神争霸赛”颁奖典礼暨年终嘉年华在成都圆满落幕,投资盛宴精彩纷呈
- 01-21年货进京1号线 戈壁红驼从草原到首都,共赴乡村振兴新征程——热烈庆祝内蒙古戈壁红驼生物科技有限责任公司入选北京地铁1号线年货进京专列
- 标签列表